“AxcelRx Live 5.0’s combination of friendly, online interface with access to more than 450,000 opted-in physicians makes it a compelling model for growing our client’s sales capabilities,” says Denis Martineau, president of Aptilon Corporation. “In addition to reaching a large number of targeted physicians, we help companies access hard-to-see physicians, as well as cover vacant or uncovered territories cost-effectively.”
AxcelRx Live 5.0 addresses the changing dynamic of the healthcare industry’s access to key targeted professionals: physicians’ increasing patient loads and administrative burdens have left little time for interacting with sales representatives, particularly during traditional office hours, and many hospitals and group practices now prohibit on-site visits by sales representatives. The corresponding decline in representative productivity has led to searches for new, efficient, and effective means of reaching and accessing critical prescribers.
Building upon the success of the existing AxcelRx platform, AxcelRx Live 5.0 offers enhanced utility for managing high volumes of interactions, additional video options, integration with online drug sample ordering, and other physician education and transaction services.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech, and medical device companies to effectively reach and interact with physicians via the Internet through its innovative live video detailing (with company reps), e-detailing, e-sampling, peer selling, and other educational content programs. Leading healthcare companies have adopted Aptilon’s “Sales Force of the Future” model, driving tens of thousands of high-quality rep-physician interactions averaging 8 to 10 minutes in length. Aptilon provides the necessary infrastructure for sales representatives to build physician awareness, understanding, and preference during all stages of a product life cycle, from pre-launch education through to end-stage support. For more information, visit www.aptilon.com.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
Forward-looking Statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
###
The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.
